HLA-C and neoplasm: Thus, active immunosurveillance imposes a selective pressure that “shapes” the immunogenicity of tumor cells and encourages/results in the escape of tumors that are less immunogenic via loss of tumor antigens and/or MHC expression (Figure 3).